Abbott Laboratories - 37 Year Stock Price History | ABT
Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits. The latest closing stock price for Abbott Laboratories as of August 10, 2020 is 100.04.
- The all-time high Abbott Laboratories stock closing price was 102.52 on July 29, 2020.
- The Abbott Laboratories 52-week high stock price is 102.89, which is 2.8% above the current share price.
- The Abbott Laboratories 52-week low stock price is 61.61, which is 38.4% below the current share price.
- The average Abbott Laboratories stock price for the last 52 weeks is 86.94.
| Abbott Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2020 | 88.9131 | 86.9500 | 102.5200 | 62.8200 | 100.0400 | 15.17% |
| 2019 | 80.5399 | 69.5000 | 88.7400 | 66.2200 | 86.8600 | 20.09% |
| 2018 | 64.2198 | 58.7900 | 74.2700 | 56.2700 | 72.3300 | 26.74% |
| 2017 | 48.5437 | 39.0500 | 57.4700 | 39.0500 | 57.0700 | 48.58% |
| 2016 | 40.4946 | 42.9300 | 45.2900 | 36.3400 | 38.4100 | -14.47% |
| 2015 | 46.3063 | 44.9000 | 51.2000 | 39.0600 | 44.9100 | -0.24% |
| 2014 | 40.9592 | 38.2300 | 46.3700 | 35.8500 | 45.0200 | 17.45% |
| 2013 | 35.6540 | 32.0500 | 38.7100 | 32.0500 | 38.3300 | -41.48% |
| 2012 | 62.7592 | 56.7200 | 72.1300 | 54.1500 | 65.5000 | 16.49% |
| 2011 | 51.0656 | 47.8200 | 56.3300 | 45.1600 | 56.2300 | 17.37% |
| 2010 | 50.7320 | 54.4600 | 56.2400 | 45.8600 | 47.9100 | -11.26% |
| 2009 | 48.4288 | 53.5600 | 57.2500 | 41.5200 | 53.9900 | 1.16% |
| 2008 | 55.1625 | 55.8100 | 60.5000 | 49.4500 | 53.3700 | -4.95% |
| 2007 | 54.4193 | 48.9700 | 59.4300 | 48.9700 | 56.1500 | 15.27% |
| 2006 | 45.0284 | 39.5500 | 49.4800 | 39.5500 | 48.7100 | 23.54% |
| 2005 | 45.3700 | 46.6700 | 49.9900 | 37.6300 | 39.4300 | -15.48% |
| 2004 | 42.3562 | 46.7500 | 46.9900 | 38.3600 | 46.6500 | 0.11% |
| 2003 | 41.2727 | 40.0500 | 47.1500 | 34.3800 | 46.6000 | 16.50% |
| 2002 | 45.8684 | 55.8400 | 57.7000 | 31.0000 | 40.0000 | -28.25% |
| 2001 | 50.0663 | 48.1300 | 56.7700 | 42.0600 | 55.7500 | 15.09% |
| 2000 | 41.6982 | 35.0000 | 55.7500 | 29.6300 | 48.4400 | 33.41% |
| 1999 | 43.6333 | 48.7500 | 52.9400 | 33.3100 | 36.3100 | -25.90% |
| 1998 | 40.9077 | 33.7200 | 49.7500 | 33.3450 | 49.0000 | 49.62% |
| 1997 | 30.8148 | 25.1900 | 34.3150 | 25.1900 | 32.7500 | 29.06% |
| 1996 | 22.6483 | 20.8750 | 28.3750 | 19.3750 | 25.3750 | 21.91% |
| 1995 | 19.2416 | 16.3150 | 22.3150 | 15.6250 | 20.8150 | 27.58% |
| 1994 | 14.8357 | 14.4400 | 16.8150 | 13.0650 | 16.3150 | 10.12% |
| 1993 | 13.4211 | 15.1900 | 15.1900 | 11.5000 | 14.8150 | -2.47% |
| 1992 | 15.3475 | 16.8125 | 17.0300 | 13.5000 | 15.1900 | -11.78% |
| 1991 | 13.0176 | 10.8125 | 17.2175 | 9.9375 | 17.2175 | 53.04% |
| 1990 | 9.5320 | 8.6563 | 11.3750 | 7.8750 | 11.2500 | 32.35% |
| 1989 | 7.3855 | 5.9688 | 8.7663 | 5.8288 | 8.5000 | 41.28% |
| 1988 | 5.8545 | 6.0788 | 6.5000 | 5.3750 | 6.0163 | -0.25% |
| 1987 | 7.1870 | 5.9375 | 8.3600 | 5.3750 | 6.0313 | 5.74% |
| 1986 | 5.4847 | 4.2500 | 6.7963 | 3.9844 | 5.7038 | 33.48% |
| 1985 | 3.4075 | 2.5394 | 4.3831 | 2.5000 | 4.2731 | 63.76% |
| 1984 | 2.6840 | 2.8750 | 3.0000 | 2.3750 | 2.6094 | -7.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $177.124B | $31.904B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $134.640B | 21.87 |
| Stryker (SYK) | United States | $70.344B | 27.28 |
| Boston Scientific (BSX) | United States | $55.768B | 32.22 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.044B | 0.00 |
| Baxter (BAX) | United States | $42.068B | 25.73 |
| Terumo (TRUMY) | Japan | $28.809B | 36.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $28.652B | 23.78 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.072B | 0.00 |
| ResMed (RMD) | United States | $25.339B | 36.80 |
| Sunny Optical Technology (SNPTF) | China | $20.401B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.905B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $15.045B | 68.05 |
| Insulet (PODD) | United States | $13.389B | 566.50 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $12.315B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.312B | 0.00 |
| Quidel (QDEL) | United States | $9.636B | 51.04 |
| GN STORE NORD (GNNDY) | Denmark | $8.157B | 41.58 |
| William Demant Holdings (WILYY) | Denmark | $7.457B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.061B | 12.12 |
| Canopy Growth (CGC) | Canada | $6.650B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.384B | 15.84 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $4.311B | 0.00 |
| Neogen (NEOG) | United States | $4.168B | 69.64 |
| Haemonetics (HAE) | United States | $4.002B | 26.67 |
| ICU Medical (ICUI) | United States | $3.727B | 28.58 |
| Envista Holdings (NVST) | United States | $3.647B | 24.87 |
| Abcam (ABCZY) | $3.548B | 0.00 | |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.538B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.913B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.828B | 439.63 |
| NuVasive (NUVA) | United States | $2.699B | 37.62 |
| TG Therapeutics (TGTX) | United States | $2.058B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $2.013B | 185.38 |
| AtriCure (ATRC) | United States | $1.896B | 0.00 |
| MacroGenics (MGNX) | United States | $1.504B | 0.00 |
| Aphria (APHA) | Canada | $1.333B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.322B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.180B | 0.00 |
| Cerus (CERS) | United States | $1.172B | 0.00 |
| Omeros (OMER) | United States | $1.162B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.092B | 0.00 |
| OraSure Technologies (OSUR) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $0.989B | 24.94 |
| Quanterix (QTRX) | United States | $0.945B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.919B | 12.73 |
| Owens & Minor (OMI) | United States | $0.878B | 19.67 |
| PetIQ (PETQ) | United States | $0.877B | 25.32 |
| Phibro Animal Health (PAHC) | United States | $0.816B | 16.26 |
| Meridian Bioscience (VIVO) | United States | $0.791B | 18.27 |
| Vapotherm (VAPO) | United States | $0.743B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.721B | 376.17 |
| VAREX IMAGING (VREX) | United States | $0.649B | 16.12 |
| Surmodics (SRDX) | United States | $0.643B | 70.52 |
| Zynex (ZYXI) | United States | $0.628B | 54.82 |
| LeMaitre Vascular (LMAT) | United States | $0.602B | 36.74 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.592B | 83.19 |
| Cytosorbents (CTSO) | United States | $0.407B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.404B | 14.44 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.339B | 0.00 |
| HEXO (HEXO) | $0.333B | 0.00 | |
| Utah Medical Products (UTMD) | $0.293B | 25.16 | |
| InfuSystems Holdings (INFU) | United States | $0.270B | 149.44 |
| Organigram Holdings (OGI) | Canada | $0.235B | 0.00 |
| Female Health (VERU) | United States | $0.214B | 0.00 |
| Chimerix (CMRX) | United States | $0.201B | 0.00 |
| Bovie Medical (APYX) | United States | $0.176B | 0.00 |
| Exagen (XGN) | United States | $0.170B | 0.00 |
| Surface Oncology (SURF) | United States | $0.168B | 0.00 |
| Fonar (FONR) | United States | $0.168B | 14.88 |
| Wound Management Technologies (SMTI) | United States | $0.166B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.133B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.126B | 0.00 |
| Evolus (EOLS) | United States | $0.125B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.119B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.115B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.087B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.086B | 0.00 |
| United-Guardian (UG) | United States | $0.071B | 15.88 |
| Nephros (NEPH) | United States | $0.068B | 0.00 |
| Brainsway (BWAY) | Israel | $0.066B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.040B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.038B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.026B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.022B | 0.00 |
| Myomo (MYO) | United States | $0.011B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
